Severe Acute Respiratory Distress Syndrome during Infliximab Therapy in a Patient with Crohn Disease
oleh: Johanna Schoehl, Nicolae-Catalin Mechie, Harald Schwoerer, Onnen Moerer, Michael Quintel, Cordula Buck, Volker Ellenrieder, Albrecht Neesse, Ahmad Amanzada
| Format: | Article |
|---|---|
| Diterbitkan: | Karger Publishers 2016-10-01 |
Deskripsi
The occurrence of a noninfectious interstitial lung disease is a rare but life-threatening side effect of infliximab, an antitumor necrosis factor alpha antibody. The following case report of a patient with Crohn disease shows an extremely dramatic progression to a severe acute respiratory distress syndrome.